ArticleBiology2021

Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study.

Timo Gaiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.